Open AccessP517: PROSPECTIVE MULTICENTRIC STUDY ON INFECTIOUS COMPLICATIONS AND CLINICAL OUTCOME IN 230 UNFIT AML PATIENTS TREATED IN FIRST‐LINE WITH HYPOMETHYLATING AGENTS ALONE OR IN COMBINATION WITH VENETOCLAX.
Author(s) -
Candoni A.,
Piccini M.,
Lazzarotto D.,
Bonuomo V.,
Dargenio M.,
Riva M.,
Mellillo L.,
Papayannidis C.,
Stulle M.,
Dragonetti G.,
Del Principe M. I.,
Cattaneo C.,
Pasciolla C.,
De Marchi R.,
Delia M.,
Tisi M. C.,
Zannier M. E.,
Nadali G.,
Sciumè M.,
Spadea A.,
Sartor C.,
Griguolo D.,
Buzzatti E.,
Basilico C. M.,
Sarlo C.,
Piccioni A. L.,
Cairoli R.,
Olivieri A.,
Pagano L.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844956.89768.84
Subject(s) - decitabine , azacitidine , medicine , neutropenia , venetoclax , hypomethylating agent , prospective cohort study , clinical trial , febrile neutropenia , leukemia , chemotherapy , biochemistry , gene expression , chemistry , chronic lymphocytic leukemia , dna methylation , gene